CDC-Authored Genomics and Precision Health Publications Database
Last data update: Jan 19, 2021. (Total: 3115 publications since 2011)
| Query Trace: Newborn screening [original query] |
|---|
| Health and economic outcomes of newborn screening for infantile-onset Pompe disease. John S Richardson, Alex R Kemper, Scott D Grosse, Wendy K K Lam, Angela M Rose, Ayesha Ahmad, Achamyeleh Gebremariam, and Lisa A Prosser Genetics in medicine : official journal of the American College of Medical Genetics 2020 Dec |
| Infants with Congenital Disorders Identified Through Newborn Screening - United States, 2015-2017. Marci K Sontag, Careema Yusuf, Scott D Grosse, Sari Edelman, Joshua I Miller, Sarah McKasson, Yvonne Kellar-Guenther, Marcus Gaffney, Cynthia F Hinton, Carla Cuthbert, Sikha Singh, Jelili Ojodu, and Stuart K Shapira MMWR. Morbidity and mortality weekly report 2020 Sep 69(36) 1265-1268 |
| Ensuring the Life-Span Benefits of Newborn Screening. Alex R Kemper, Coleen A Boyle, Jeffrey P Brosco, and Scott D Grosse Pediatrics 2019 Nov |
| Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease. Lisa A Prosser, K K Lam, Scott D Grosse, Mia Casale, and Alex R Kemper MDM policy & practice 3(1) |
| Primary Care Provider Management of Congenital Hypothyroidism Identified Through Newborn Screening. N A Rosenthal, E Bezar, S Mann, L K Bachrach, S Banerjee, M E Geffner, M Gottschalk, S K Shapira, L Hasegawa, and L Feuchtbaum Annals of thyroid research 2017 3(1) 95-101 |
| Newborn Screening Quality Assurance Program for CFTR Mutation Detection and Gene Sequencing to Identify Cystic Fibrosis. Miyono M Hendrix, Stephanie L Foster, and Suzanne K Cordovado Journal of inborn errors of metabolism and screening 4 |
| Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid a-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease. Na Lin, Jingyu Huang, Sara Violante, Joseph J Orsini, Michele Caggana, Erin E Hughes, Colleen Stevens, Lisa DiAntonio, Hsuan Chieh Liao, Xinying Hong, Farideh Ghomashchi, Arun Babu Kumar, Hui Zhou, Ruth Kornreich, Melissa Wasserstein, Michael H Gelb, and Chunli Yu Clinical chemistry 2017 Feb |
| Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Alex R Kemper, Jeffrey Brosco, Anne Marie Comeau, Nancy S Green, Scott D Grosse, Elizabeth Jones, Jennifer M Kwon, Wendy K K Lam, Jelili Ojodu, Lisa A Prosser, and Susan Tanksley Genetics in medicine : official journal of the American College of Medical Genetics 2017 19(1) 121-126 |
| A framework for assessing outcomes from newborn screening: on the road to measuring its promise. Cynthia F Hinton, Charles J Homer, Alexis A Thompson, Andrea Williams, Kathryn L Hassell, Lisa Feuchtbaum, Susan A Berry, Anne Marie Comeau, Bradford L Therrell, Amy Brower, Katharine B Harris, Christine Brown, Jana Monaco, Robert J Ostrander, Alan E Zuckerman, Celia Kaye, Denise Dougherty, Carol Greene, Nancy S Green, and Molecular genetics and metabolism 2016 May |
| Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State. Yao Ding, John D Thompson, Lisa Kobrynski, Jelili Ojodu, Guisou Zarbalian, and Scott D Grosse The Journal of pediatrics 2016 Feb |
| The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study. Maria D Karaceper, Pranesh Chakraborty, Doug Coyle, Kumanan Wilson, Jonathan B Kronick, Steven Hawken, Christine Davies, Marni Brownell, Linda Dodds, Annette Feigenbaum, Deshayne B Fell, Scott D Grosse, Astrid Guttmann, Anne-Marie Laberge, Aizeddin Mhanni, Fiona A Miller, John J Mitchell, Meranda Nakhla, Chitra Prasad, Cheryl Rockman-Greenberg, Rebecca Sparkes, Brenda J Wilson, Beth K Potter, and Orphanet journal of rare diseases 2016 Feb 1112 |
| Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis. Scott D Grosse Healthcare (Basel, Switzerland) 2015 3(4) 1133-57 |
| Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium. Frédéric B Piel, Thomas V Adamkiewicz, Djesika Amendah, Thomas N Williams, Sunetra Gupta, and Scott D Grosse Genetics in medicine : official journal of the American College of Medical Genetics 2015 Dec |
| Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states. Patrice K Held, Stuart K Shapira, Cynthia F Hinton, Elizabeth Jones, W Harry Hannon, and Jelili Ojodu Mol. Genet. Metab. 2015 Aug 12. |
| Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study. Mei W Baker, Anne E Atkins, Suzanne K Cordovado, Miyono Hendrix, Marie C Earley, and Philip M Farrell Genet. Med. 2015 Feb 12. |
| Universal state newborn screening programs can reduce health disparities. Jeffrey P Brosco, Scott D Grosse, and Lainie Friedman Ross JAMA Pediatr 2015 Jan 169(1) 7-8 |
| Mortality of New York children with sickle cell disease identified through newborn screening. Ying Wang, Gang Liu, Michele Caggana, Joseph Kennedy, Regina Zimmerman, Suzette O Oyeku, Ellen M Werner, Althea M Grant, Nancy S Green, and Scott D Grosse Genet. Med. 2015 Jun 17(6) 452-9 |
| Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs. Víctor R De Jesús, Barbara W Adam, Daniel Mandel, Carla D Cuthbert, and Dietrich Matern Mol. Genet. Metab. 113(1-2) 67-75 |
| Reflections on 50 years of newborn screening. Coleen A Boyle, Joseph A Bocchini, and James Kelly Pediatrics 2014 Jun 133(6) 961-3 |
| Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings. Cynthia F Hinton, Cara T Mai, Sarah K Nabukera, Lorenzo D Botto, Lisa Feuchtbaum, Paul A Romitti, Ying Wang, Kimberly Noble Piper, and Richard S Olney Genet. Med. 2014 Jun 16(6) 484-90 |
| Newborn screening: from Guthrie to whole genome sequencing. Michele Caggana, Elizabeth A Jones, S I Shahied, Susan Tanksley, Cheryl A Hermerath, and Ira M Lubin Public Health Rep 128 Suppl 214-9 |
| Public health action in genomics is now needed beyond newborn screening. M S Bowen, K Kolor, W D Dotson, R M Ned, and M J Khoury Public health genomics 2012 15(6) 327-34 |
| Improving newborn screening follow-up in pediatric practices: quality improvement innovation network. Cynthia F Hinton, Daniel R Neuspiel, Ruth S Gubernick, Timothy Geleske, Jill Healy, Alex R Kemper, Michele A Lloyd-Puryear, Robert A Saul, Barry H Thompson, and Celia I Kaye Pediatrics 2012 Sep 130(3) e669-75 |
| CDC Grand Rounds: Newborn screening and improved outcomes. MMWR. Morbidity and mortality weekly report 2012 Jun 61(21) 390-3 |
| Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening. Christopher A Haynes, and Víctor R De Jesús Clin. Chim. Acta 2012 Aug 16. 413(15-16) 1217-21 |
| Decision analysis, economic evaluation, and newborn screening: challenges and opportunities. Lisa A Prosser, Scott D Grosse, Alex R Kemper, Beth A Tarini, and James M Perrin Genet. Med. 2012 Apr 5. |
| Evidence-based path to newborn screening for Duchenne muscular dystrophy. Jerry R Mendell, Chris Shilling, Nancy D Leslie, Kevin M Flanigan, Roula al-Dahhak, Julie Gastier-Foster, Kelley Kneile, Diane M Dunn, Brett Duval, Alexander Aoyagi, Cindy Hamil, Maha Mahmoud, Kandice Roush, Lauren Bird, Chelsea Rankin, Heather Lilly, Natalie Street, Ram Chandrasekar, and Robert B Weiss Ann. Neurol. 2012 Mar 71(3) 304-13 |
| What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children. Cynthia F Hinton, Lisa Feuchtbaum, Christopher A Kus, Alex R Kemper, Susan A Berry, Jill Levy-Fisch, Julie Luedtke, Celia Kaye, and Coleen A Boyle Genet. Med. 2011 Oct 13(10) 861-5 |
| Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States. Vicki S Hertzberg, Cynthia F Hinton, Bradford L Therrell, and Stuart K Shapira J. Pediatr. 2011 Oct 159(4) 555-60 |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: